PZ Cormay SA
WSE:CRM
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.354
0.588
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| PL |
P
|
PZ Cormay SA
WSE:CRM
|
33.6m PLN |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.6T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
30.8B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
36.4B USD |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
120.8B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.1B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.8B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD |
Loading...
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.7T KRW |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.3B CHF |
Loading...
|
Market Distribution
| Min | -10 083 900% |
| 30th Percentile | -1.5% |
| Median | 5.4% |
| 70th Percentile | 11.7% |
| Max | 195 905.3% |
Other Profitability Ratios
PZ Cormay SA
Glance View
PZ Cormay SA engages in the manufacture of diagnostic reagents and laboratory equipment. The company is headquartered in Lomianki, Woj. Mazowieckie and currently employs 218 full-time employees. The company went IPO on 2008-08-20. The firm is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. The company offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for PZ Cormay SA is -1.7%, which is above its 3-year median of -4.7%.
Over the last 3 years, PZ Cormay SA’s Operating Margin has increased from -2.5% to -1.7%. During this period, it reached a low of -7.7% on Jun 30, 2024 and a high of -1.7% on Oct 30, 2025.